Literature DB >> 7948948

Post-translational modification of p53.

D W Meek1.   

Abstract

The p53 tumor suppressor protein is extensively post-translationally modified, mostly by phosphorylation. The phosphorylation sites are clustered into two distinct domains within the p53 polypeptide and the protein kinases and phosphatases which modify many of these sites have been identified. In addition, signaling pathways which modulate the phosphorylation state of p53, leading perhaps to changes in its activity, are being actively investigated. Similarly, the transforming proteins of DNA tumor viruses modulate p53 phosphorylation and may therefore be useful tools for probing these regulatory mechanisms. Given the very potent effects of p53 on cell growth and the extent of phosphorylation of this protein, p53 may well be controlled tightly and coordinately by more than one signaling mechanism.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7948948

Source DB:  PubMed          Journal:  Semin Cancer Biol        ISSN: 1044-579X            Impact factor:   15.707


  29 in total

1.  Protein kinase CK2-dependent regulation of p53 function: evidence that the phosphorylation status of the serine 386 (CK2) site of p53 is constitutive and stable.

Authors:  L McKendrick; D Milne; D Meek
Journal:  Mol Cell Biochem       Date:  1999-01       Impact factor: 3.396

Review 2.  Acetylation of histones and transcription-related factors.

Authors:  D E Sterner; S L Berger
Journal:  Microbiol Mol Biol Rev       Date:  2000-06       Impact factor: 11.056

3.  Transgenic mice with p53-responsive lacZ: p53 activity varies dramatically during normal development and determines radiation and drug sensitivity in vivo.

Authors:  E A Komarova; M V Chernov; R Franks; K Wang; G Armin; C R Zelnick; D M Chin; S S Bacus; G R Stark; A V Gudkov
Journal:  EMBO J       Date:  1997-03-17       Impact factor: 11.598

4.  NF-kappaB prevents cells from undergoing Cr(VI)-induced apoptosis.

Authors:  Suwei Wang; Fei Chen; Zhuo Zhang; Bing-hua Jiang; Luo Jia; Xianglin Shi
Journal:  Mol Cell Biochem       Date:  2004-01       Impact factor: 3.396

Review 5.  Self-regulatory role of 4-hydroxynonenal in signaling for stress-induced programmed cell death.

Authors:  Yogesh C Awasthi; Rajendra Sharma; Abha Sharma; Sushma Yadav; Sharad S Singhal; Pankaj Chaudhary; Sanjay Awasthi
Journal:  Free Radic Biol Med       Date:  2008-05-02       Impact factor: 7.376

6.  Identification of an additional negative regulatory region for p53 sequence-specific DNA binding.

Authors:  B F Müller-Tiemann; T D Halazonetis; J J Elting
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-26       Impact factor: 11.205

7.  Proteolytic cleavage of human p53 by calpain: a potential regulator of protein stability.

Authors:  M H Kubbutat; K H Vousden
Journal:  Mol Cell Biol       Date:  1997-01       Impact factor: 4.272

8.  BRCA1 regulates p53-dependent gene expression.

Authors:  T Ouchi; A N Monteiro; A August; S A Aaronson; H Hanafusa
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-03       Impact factor: 11.205

9.  The physical association of multiple molecular chaperone proteins with mutant p53 is altered by geldanamycin, an hsp90-binding agent.

Authors:  L Whitesell; P D Sutphin; E J Pulcini; J D Martinez; P H Cook
Journal:  Mol Cell Biol       Date:  1998-03       Impact factor: 4.272

10.  Discovery, in vivo activity, and mechanism of action of a small-molecule p53 activator.

Authors:  Sonia Lain; Jonathan J Hollick; Johanna Campbell; Oliver D Staples; Maureen Higgins; Mustapha Aoubala; Anna McCarthy; Virginia Appleyard; Karen E Murray; Lee Baker; Alastair Thompson; Joanne Mathers; Stephen J Holland; Michael J R Stark; Georgia Pass; Julie Woods; David P Lane; Nicholas J Westwood
Journal:  Cancer Cell       Date:  2008-05       Impact factor: 31.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.